Edwards Lifesciences Corp.

EW05 Dec 2024
Healthcare
$71.86
+0.06 (+5.74%)
Lowest Today
$71.72
Highest Today
$74.68
Today’s Open
$71.86
Prev. Close
$70.2
52 Week High
$96.12
52 Week Low
$58.93
To Invest in Edwards Lifesciences Corp.

Edwards Lifesciences Corp.

Healthcare
EW05 Dec 2024
+0.06 (+5.74%)
1M
3M
6M
1Y
5Y
Low
$71.72
Day’s Range
High
$74.68
71.72
52 Week Low
$58.93
52-Week Range
52 Week High
$96.12
58.93
1 Day
-
1 Week
-2.55%
1 month return
+5.61%
3 month return
+1.85%
6 month return
-19.67%
1 Year return
+1.5%
3 Years return
-37.28%
5 Years return
-14.47%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
10.61
BlackRock Inc
8.64
Wellington Management Company LLP
5.35
State Street Corp
4.45
Vanguard Total Stock Mkt Idx Inv
3.23
Bank of New York Mellon Corp
3.1
Vanguard Institutional 500 Index Trust
2.71

Market Status

Fundamentals
Market Cap
42018.39 mln
PB Ratio
4.41
PE Ratio
27.23
Enterprise Value
38342.83 mln
Total Assets
9363.2 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Organisation
Edwards Lifesciences Corp.
Employees
19800
Industry
Medical Devices
CEO
Mr. Bernard J. Zovighian
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities